George, S., Motzer, R. J., Hammers, H. J., Redman, B. G., Kuzel, T. M., Tykodi, S. S., . . . Rini, B. I. (2016). Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial. JAMA Oncol.
Stile di citazione ChicagoGeorge, Saby, et al. "Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial." JAMA Oncol 2016.
Citazione MLAGeorge, Saby, et al. "Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial." JAMA Oncol 2016.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.